| Vahid Etezadi, MD | |
|
22 S Greene St, Dept Of Radiology, Baltimore, MD 21201-1544 | |
| (410) 328-3477 | |
| Not Available |
| Full Name | Vahid Etezadi |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 23 Years |
| Location | 22 S Greene St, Dept Of Radiology, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225357718 | NPI | - | NPPES |
| 100494801 | Medicaid | MD | |
| 024995813 | Medicaid | DC |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Maryland Medical Center | Baltimore, MD | Hospital |
| University Of Md Charles Regional Medical Center | La plata, MD | Hospital |
| Howard University Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland Diagnostic Imaging Specialists, P A | 7719873298 | 81 |
News Archive
MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.
› Verified 5 days ago
| Entity Name | St. Agnes Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144250176 PECOS PAC ID: 9830092733 Enrollment ID: O20040128001146 |
News Archive
MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.
› Verified 5 days ago
| Entity Name | University Of Maryland Diagnostic Imaging Specialists, P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154335487 PECOS PAC ID: 7719873298 Enrollment ID: O20040223000685 |
News Archive
MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.
› Verified 5 days ago
| Entity Name | University Imaging Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245245307 PECOS PAC ID: 2769378686 Enrollment ID: O20040226000325 |
News Archive
MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.
› Verified 5 days ago
| Entity Name | University Of Maryland Diagnostic Radiology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467996959 PECOS PAC ID: 0345513248 Enrollment ID: O20170828004107 |
News Archive
MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vahid Etezadi, MD 8712 Snowhill Ct, Potomac, MD 20854-4411 Ph: (786) 333-7599 | Vahid Etezadi, MD 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201-1544 Ph: (410) 328-3477 |
News Archive
MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.
› Verified 5 days ago
Dr. Barun Aryal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Dept Of Internal Medicine, Baltimore, MD 21225 Phone: 410-350-3565 Fax: 410-354-0186 | |
Imran Ahmed, D.O Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201 Phone: 410-328-3477 | |
Michael Goldman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Radiology Dept, Baltimore, MD 21202 Phone: 410-332-9266 Fax: 410-545-4255 | |
Dr. Jeffrey R. Galvin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201 Phone: 410-328-3477 | |
Martin Auster, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0214 | |
Amy K Pepperney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7253 Ambassador Rd, Baltimore, MD 21244 Phone: 443-436-1151 Fax: 443-436-1256 | |
Carolyn Kwon, Radiology Medicare: May Accept Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0100 |